Product Details
Product Name:
Suptavumab |
CAS No.:
1629615-23-1 |
Purity:
99.2% (SEC-HPLC) |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | Suptavumab |
Description | Suptavumab (REGN2222) is a human monoclonal antibody that neutralizes conserved epitopes on subtypes A and B of RSV, making it useful for studying RSV infections and the respiratory system. |
In vitro | Suptavumab inhibits the fusion of RSV with cells. It is a human monoclonal antibody targeting the prefusion conformation of the RSV [fusion] glycoprotein and has potent neutralizing activity against RSV group A and RSV group B. |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Keywords | Suptavumab | REGN-2222 | REGN 2222 |
Inhibitors Related | BTA-9881 | Rilematovir | VV116 | Ribavirin | Ziresovir | 4-Methoxycinnamaldehyde | Roflumilast | Enzaplatovir | Totrombopag | KIN101 | Presatovir | Amentoflavone |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:189940-24-7
$1980.00 / 50mg
-
CAS:53882-13-6
$85.00 / 1mg
-
CAS:849461-90-1
$53.00 / 5mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |